SCHEMBL30221690

SCHEMBL30221690

COc1cnc(Nc2ccc(N(C)CCN(C)C)c(NC(C)=O)c2)nc1-c1c[nH]c2ccccc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 13/20 0.62
▸ KCNH2 Q12809 4/20 0.62
▸ IGF1R P08069 2/20 0.62
▸ CDK1 P06493 3/20 0.49
▸ KDR P35968 1/20 0.49
▸ CDK7 P50613 6/20 0.46
▸ CCNH P51946 6/20 0.46
▸ CDK2 P24941 2/20 0.46
▸ CDK9 P50750 2/20 0.46
▸ MNAT1 P51948 2/20 0.46
▸ CDK5 Q00535 2/20 0.46
▸ CCNT1 O60563 1/20 0.46
▸ CCNK O75909 1/20 0.46
▸ CCNB1 P14635 1/20 0.46
▸ CCNA2 P20248 1/20 0.46
▸ MAPK8 P45983 1/20 0.46
▸ MAPK9 P45984 1/20 0.46
▸ CDK13 Q14004 1/20 0.46
▸ CDK5R1 Q15078 1/20 0.46
▸ MAP3K11 Q16584 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24900456 1.00 EGFR (0.62) EGFRKCNH2IGF1RCDK1KDR
SCHEMBL24900457 0.91 EGFR (0.54) EGFRKCNH2IGF1R
SCHEMBL31503148 0.91 EGFR (0.54) EGFRKCNH2IGF1R
SCHEMBL24900787 0.91 EGFR (0.58) EGFRKCNH2IGF1RCDK1KDR
SCHEMBL24900731 0.90 EGFR (0.54) EGFRKCNH2IGF1RCDK1KDR
SCHEMBL30221619 0.90 EGFR (0.54) EGFRKCNH2IGF1RCDK1KDR
SCHEMBL24900802 0.90 EGFR (0.65) EGFRKCNH2IGF1RCDK1KDR
SCHEMBL30221514 0.89 EGFR (0.50) EGFRKCNH2IGF1R
SCHEMBL24900801 0.88 CDK7 (0.58) EGFRKCNH2IGF1RCDK1KDR
SCHEMBL24900836 0.85 EGFR (0.59) EGFRKCNH2IGF1RCDK1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023287783-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF ACEA Therapeutics, Inc. (US) 2023-01-19 — — WO disclosed
Send feedback